EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Financial incentives for quitting smoking in pregnancy: Are they cost‐effective?

Nicola McMeekin iD, Lesley Sinclair, Lyn Robinson-Smith, Alex Mitchell, Linda Bauld, David M Tappin, Kathleen A Boyd

Addiction · 2023

DOI: 10.1111/add.16176 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Addiction, 2023. Verfasst von Nicola McMeekin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK. Hauptthemen laut MEDLINE: Smoking Cessation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Chief Scientist Office, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate whether adding financial incentives to usual care is cost‐effective in encouraging pregnant women to quit tobacco smoking, compared with usual care alone.

Design

Cost‐effectiveness analysis (CEA) and cost–utility analysis (CUA) from a health‐care provider's perspective, embedded in the Smoking Cessation in Pregnancy Incentives Trial (CPIT III). Long‐term analyses were conducted from the same perspective, using an existing Markov model over a life‐time horizon.

Setting

Seven maternity smoking cessation sites in Scotland, England and Northern Ireland in the United Kingdom.

Participants

In the short‐term analysis, CPIT III participants were assessed: women 16 years or older, self‐reporting as smokers, fewer than 24 weeks pregnant and English‐speaking ( n = 944). The same population was used for the life‐time analysis, plus their infants.

Measurements

Costs included financial incentive vouchers and postage, cessation support and nicotine replacement therapy and neonatal stays. The outcome measure was a biochemically verified quit rate for the CEA and quality‐adjusted life‐years (QALYs) for CUA. Costs are presented in 2020 GBP sterling (£). Data for the life‐time analysis came from the trial and were combined with data from published literature embedded in the model, reporting incremental cost per quitter and QALY. A 3.5% discount rate was applied.

Findings

The short‐term incremental cost per quitter was £4400 and cost per QALY was £150 000. Results of sensitivity analyses confirmed these results. The long‐term analysis combined costs and outcomes for mother and infants; results showed a cost saving of £37 [95% confidence interval (CI]) = £35–106] and increase in QALYs of 0.171 (95% CI = 0.124–0.229). These findings indicate that, over a life‐time, financial incentives are cost‐saving and improve health outcomes.

Conclusions

In the United Kingdom, offering up to £400 financial incentives, in addition to usual care, to support pregnant women to stop smoking appears to be highly cost‐effective over a life‐time for mother and infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationFemaleHumansInfant, NewbornPregnancyCost-Benefit AnalysisMotivationSmokingTobacco SmokingTobacco Use Cessation Devices

Stichwörter der Autor:innen

Child healthcost-effectiveness analysiseconomic evaluationfinancial incentivespregnancysmoking cessation

Autor:innen und Institutionen

  • Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, G12 8RZ, UK.
  • York Trials Unit, Department of Health Sciences, Faculty of Science, University of York, YO10 5DD, York, UK.
  • Usher Institute and SPECTRUM Consortium, University of Edinburgh, Edinburgh, EH8 9AG, UK.
  • Child Health, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.

ORCID-Profile: Nicola McMeekin

Förderung

  • Cancer Research UK
  • Chief Scientist Office
  • Medical Research Council
  • Health and Social Care Northern Ireland
  • Lullaby Trust
  • Northern Ireland Chest Heart and Stroke
  • Scottish Cot Death Trust

Zitieren

APA

McMeekin, N., Sinclair, L., Robinson-Smith, L., Mitchell, A., Bauld, L., Tappin, D. M., & Boyd, K. A. (2023). Financial incentives for quitting smoking in pregnancy: Are they cost‐effective?. Addiction. https://doi.org/10.1111/add.16176

Vancouver

McMeekin N, Sinclair L, Robinson-Smith L, Mitchell A, Bauld L, Tappin DM, et al. Financial incentives for quitting smoking in pregnancy: Are they cost‐effective?. Addiction. 2023. doi:10.1111/add.16176

BibTeX
@article{McMeekin2023,
  author = {McMeekin, Nicola and Sinclair, Lesley and Robinson-Smith, Lyn and Mitchell, Alex and Bauld, Linda and Tappin, David M and Boyd, Kathleen A},
  title = {Financial incentives for quitting smoking in pregnancy: Are they cost‐effective?},
  journal = {Addiction},
  year = {2023},
  doi = {10.1111/add.16176}
}
Kostenlos starten →